Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series by Matteo Megna, Gabriella Fabbrocini, Lucia Gallo, Angelo Ruggiero, Elisa Camela, Sonia Sofía Ocampo-Garza, Eleonora Cinelli

Get full text

Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19 by Peter C. M. van de Kerkhof

Get full text

Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience by Giacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, Mauro Bavetta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Luca Bianchi, Clara De Simone, Ketty Peris

Subjects: Get full text

Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis by Tanat Yongpisarn, Amornrut Namasondhi, Wimolsiri Iamsumang, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit

“…BackgroundPatients with psoriasis are more likely than matched controls in the general population to have advanced liver fibrosis; however, our understanding of these patients is limited. …”
Get full text

Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis by Francesco Carubbi, Rosaria Fidanza, Maria Palmieri, Alessandra Ventura, Sara Tambone, Paola Cipriani, Roberto Giacomelli, Maria Concetta Fargnoli

Subjects: “…psoriasis…”
Get full text

Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy by Ylenia Ingrasciotta, Valentina Isgrò, Valentina Ientile, Michele Tari, Gianluca Trifirò, Claudio Guarneri

Subjects: Get full text

Treatment of Mild to Moderate Plaque Psoriasis with Pimecrolimus, Clobetasol, or Calcipotriol Cream: A comparative study by Bahir A.R. Mshimesh

Subjects: “…psoriasis; pimecrolimus; clobetasol; calcipotriol; efficacy; safety.…”
Get full text

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Subjects: “…Psoriasis…”
Get full text

It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis by Umar N, Schöllgen I, Terris DD

“…The purpose of this study was to examine the features of psoriasis treatment that are most and least preferred by patients and to identify correlates of these preferences.Methods: A cross-sectional survey of 163 patients with moderate-to-severe psoriasis was conducted in a German academic medical center. …”
Get full text

Lithosepermic Acid Restored the Skin Barrier Functions in the Imiquimod-Induced Psoriasis-like Animal Model by Li-Ching Chen, Yu-Ping Cheng, Chih-Yi Liu, Jiun-Wen Guo

Subjects: Get full text

Prevalencia de psoriasis en Colombia según datos del Registro Nacional en Salud by D.G. Fernández-Ávila, L.P. Charry Anzola, L.P. González-Cardona

Get full text

Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris, by Jéssica Vianna Starek, Cristina Santos Ribeiro Bechara, Mariana Reis e Rocha Dultra, Juliana de Morais Fernandes Krakheche

Get full text

Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism by Qixiang Zhao, Jiadong Yu, Hong Zhou, Xiaoyan Wang, Chen Zhang, Jing Hu, Yawen Hu, Huaping Zheng, Fanlian Zeng, Chengcheng Yue, Linna Gu, Zhen Wang, Fulei Zhao, Pei Zhou, Haozhou Zhang, Nongyu Huang, Wenling Wu, Yifan Zhou, Jiong Li

“…Abstract The intestinal microbiota has been associated with host immunity as well as psoriasis; however, the mechanism of intestinal microbiota regulating psoriasis needs to be demonstrated systematically. …”
Get full text

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice by L.S. van der Schoot, J.J. Janssen, M.T. Bastiaens, A. de Boer-Brand, C. Christiaansen-Smit, D.N.H. Enomoto, R. Hovingh, R.A. Tupker, M.M.B. Seyger, L.M. Verhoef, J.M.P.A. van den Reek, E.M.G.J. de Jong

Subjects: “…psoriasis…”
Get full text

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study by Constanze Jonak, Isolde Göttfried, Sylvia Perl-Convalexius, Barbara Gruber, Martina Schütz-Bergmayr, Igor Vujic, Wolfgang Weger, Nikolaus Schicher, Lydia Semlin, Margit Hemetsberger, Myriam Cordey, Paul Sator

“…Background: Apremilast, an oral phosphodiesterase 4 inhibitor, is approved in the European Union for the treatment of moderate-to-severe chronic plaque psoriasis in adult patients refractory or contraindicated to or intolerant of other systemic therapies. …”
Get full text

Undifferentiated seronegative spondyloarthritis with inflammatory bowel disease and a family history of psoriasis. Sicca syndrome by Norma Marigliano, Domenico Galasso

Subjects: Get full text

Two Track Biologic Therapy for Concurrent Chronic Spontaneous Urticaria and Psoriasis Vulgaris in One Patient by M. Benko, B. Hrvatin Stancic, T. Lunder

Get full text

Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States by Jashin J. Wu, Steven R. Feldman, Shipra Rastogi, Brandy Menges, Melissa Lingohr-Smith, Jay Lin

Subjects: Get full text

Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report and literature review by Luyang Kong, Luyang Kong, Dawei Huang, Dawei Huang, Jiajing Lu, Jiajing Lu, Yuexin Zhang, Yuexin Zhang, Ying Li, Ying Li, Xuemei Yi, Xuemei Yi, Yuling Shi, Yuling Shi

Subjects: Get full text

Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder’s role in psoriasis treatment by Bin Tang, Bin Tang, Bin Tang, Bin Tang, Xuwei Zheng, Qianqian Luo, Xiong Li, Yujie Yang, Yang Bi, Yonggen Chen, Ling Han, Ling Han, Ling Han, Ling Han, Haiming Chen, Haiming Chen, Haiming Chen, Haiming Chen, Chuanjian Lu, Chuanjian Lu, Chuanjian Lu, Chuanjian Lu

Subjects: Get full text